Note: Ingredients listed on restricted chemical lists
EC/CAS
10605-21-7
Name of the chemical
Carbendazim (ISO); Methylbenzimidazol- 2-ylcarbamat (2021/849)
Concentration
N/A
General Information
Version
5.8. Revision Date
Revision date
2026-05-09
Product name
methyl N-(1H-1,3-benzodiazol-2-yl)carbamate
Product name
methyl N-(1H-1,3-benzodiazol-2-yl)carbamate
Identification on the label/Trade name
EN300-180487
CAS No.
10605-21-7
1.2.1 Relevant identified uses
of the substance and restrictions on use
supplier name
ENAMINE Ltd
Emergency telephone
+380 44 5373218, +380 44 5373253
Icons in SDS
Company Information
company name
ENAMINE Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@enamine.net
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H360FD, H410
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance / mixture
2.2 Label elements
1
Hazard pictograms
� � � � � � � � � �
Signal word
Danger
Hazard statements
H410 Very toxic to aquatic life with long lasting effects H340 May cause genetic defects H360FD May damage fertility. May damage the unborn child
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards
N/A
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Hazardous to the aquatic environment, chronic hazard(Category 1), H410 Germ cell mutagenicity(Category 1B), H340 Reproductive toxicity(Category 1B), H360FD For the full text of the H-Statements mentioned in this Section, see Section 2.2.